|
Title: RAPPLER VS DENGVAXIA Post by: playful69 on February 21, 2018, 10:55:41 PM isn't it ai and appalling that the YELLOW LP's are more concerned about the supposedly "suppressed press freedom" of rappler than the endangered lives of the people victimized by Dengvaxia?
the countdown of related Dengvaxia deaths are now slowly becoming alarming. the DOJ should punish the guilty and start filing criminal charges left and right. Title: Re: RAPPLER VS DENGVAXIA Post by: Mometaskers on February 22, 2018, 02:12:02 AM isn't it ai and appalling that the YELLOW LP's are more concerned about the supposedly "suppressed press freedom" of rappler than the endangered lives of the people victimized by Dengvaxia? the countdown of related Dengvaxia deaths are now slowly becoming alarming. the DOJ should punish the guilty and start filing criminal charges left and right. Hi, since you are talking about this, I'm assuming you are Filipino. What I'm curious is why these reports of deaths are only occurring in the Philippines when Mexico was the first to launch the vaccine and Brazil also had a significant vaccination program. https://www.reuters.com/article/us-sanofi-dengue/trouble-mounts-for-sanofi-dengue-vaccine-over-safety-concerns-idUSKBN1DY26Y Quote Brazilian health regulator Anvisa, in an emailed statement to Reuters, said it had not received any reports of vaccine recipients dying or falling more severely ill because of the drug. It does not know how many people have received the vaccine in Brazil since its 2015 approval. Quote In addition to Brazil, the Philippines and Singapore, Dengvaxia is being sold in Mexico, Indonesia, Thailand, Paraguay, Peru, Costa Rica, El Salvador and Guatemala. Health officials in Mexico, the first country to approve the vaccine in 2015, and in Peru had no immediate comment. Paraguay’s health officials said Dengvaxia is not widely used due to cost but that they have not received reports of problems from doctors who provide the vaccine. It is approved but not yet launched in Honduras, Malaysia, Australia, Argentina, Venezuela, Bolivia, Bangladesh and Cambodia. Of course there may be differences in vaccination rates so that may have affected the results. |